Callisto Pharmaceuticals' Clinical Study of Atiprimod in Multiple Myeloma Patients Expanded to Additional Clinical Site.
PR Newswire Europe, July, 2006
NEW YORK, July 27 /PRNewswire/ --
- University of Michigan Comprehensive Cancer Center Commences Enrollment of Multiple Myeloma Patient in Phase I/IIa Clinical Trial
Callisto Pharmaceuticals, Inc. (Amex: KAL)(FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced today the expansion of its ongoing Phase I/IIa clinical trial of Atiprimod to treat relapsed or refractory multiple myeloma patients to an additional clinical trial site, the University of Michigan Comprehensive Cancer Center.
The first patient at the University of Michigan site was enrolled on July 25, 2006 under the direction of Dr. Andrzej Jakubowiak, the principal investigator at the University of Michigan.
"We...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Getting the global view: Nestle, led by Peter Brabeck-Letmathe, climbs to the #1 spot in this year's Best Companies for Leaders
